FGFR3 and Alzheimer disease: In summary, while EE intervention did not have a significant impact on the regulation of other neurotransmitters, such as catecholamines, glutamate, GABA, and enkephalin, the analysis of neurotransmitter‐related analysis offers insights into the therapeutic mechanism by which EE intervention alleviates cognitive dysfunction through the regulation of Ach, 5‐HT, and polyamines levels in the brain of patients with AD.